z-logo
open-access-imgOpen Access
Hospital-acquired pneumonia due to Achromobacter xylosoxidans in the elderly: A single-center retrospective study in Beijing
Author(s) -
Chao Liu,
Jun Guo,
Weifeng Yan,
Yi Jin,
Fei Pan,
Xiangqun Fang,
Long Qin,
Changting Liu
Publication year - 2017
Publication title -
the journal of infection in developing countries
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.322
H-Index - 49
eISSN - 2036-6590
pISSN - 1972-2680
DOI - 10.3855/jidc.8747
Subject(s) - imipenem , medicine , achromobacter xylosoxidans , tazobactam , cefoperazone , pneumonia , sulbactam , levofloxacin , piperacillin , cilastatin , antibiotics , microbiology and biotechnology , pseudomonas aeruginosa , antibiotic resistance , genetics , bacteria , biology
Achromobacter xylosoxidans has been reported in several countries; however, hospital-acquired pneumonia (HAP) due to this organism in elderly patients in China remains rare.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom